This bile acid can act as an agonist of the Farnesoid X receptor (FXR) superfamily, regulating bile acid homeostasis and lipid metabolism, reducing bile acids, and contributing to hepatic steatosis [27,28]. The gene discussed is NR1H4; the disease is Hepatic steatosis.